Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Equities researchers at William Blair decreased their Q3 2017 earnings per share (EPS) estimates for Acadia Healthcare in a report released on Thursday. William Blair analyst R. Daniels now anticipates that the company will earn $0.66 per share for the quarter, down from their previous estimate of $0.67. William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for Acadia Healthcare’s Q4 2017 earnings at $0.68 EPS and FY2017 earnings at $2.45 EPS.
ACHC has been the subject of a number of other research reports. Deutsche Bank AG started coverage on Acadia Healthcare in a research report on Wednesday, April 5th. They set a “buy” rating and a $53.00 price target for the company. Zacks Investment Research upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, April 28th. Jefferies Group LLC set a $55.00 price target on Acadia Healthcare and gave the stock a “buy” rating in a research report on Thursday, June 1st. Leerink Swann lowered Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research report on Monday, May 15th. Finally, Cantor Fitzgerald reiterated a “hold” rating and set a $45.00 price target on shares of Acadia Healthcare in a research report on Wednesday, April 26th. Four research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. Acadia Healthcare presently has an average rating of “Buy” and a consensus target price of $59.21.
Shares of Acadia Healthcare (NASDAQ:ACHC) opened at 52.93 on Monday. The firm has a market cap of $4.65 billion, a P/E ratio of 581.65 and a beta of 1.13. Acadia Healthcare has a 12-month low of $32.54 and a 12-month high of $54.73. The firm has a 50-day moving average price of $48.70 and a 200-day moving average price of $43.91.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. During the same quarter last year, the company earned $0.73 earnings per share. Acadia Healthcare’s quarterly revenue was down 5.4% compared to the same quarter last year.
Large investors have recently made changes to their positions in the stock. BlackRock Inc. increased its stake in Acadia Healthcare by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after buying an additional 5,127,140 shares in the last quarter. Aristotle Capital Management LLC acquired a new position in shares of Acadia Healthcare during the first quarter worth $140,071,000. FMR LLC increased its position in shares of Acadia Healthcare by 173.2% in the first quarter. FMR LLC now owns 2,195,002 shares of the company’s stock worth $95,702,000 after buying an additional 1,391,552 shares during the period. Frontier Capital Management Co. LLC increased its position in shares of Acadia Healthcare by 112.2% in the first quarter. Frontier Capital Management Co. LLC now owns 2,087,088 shares of the company’s stock worth $90,997,000 after buying an additional 1,103,446 shares during the period. Finally, Point72 Asset Management L.P. increased its position in shares of Acadia Healthcare by 143.4% in the first quarter. Point72 Asset Management L.P. now owns 1,085,000 shares of the company’s stock worth $47,306,000 after buying an additional 639,300 shares during the period.
In other news, Director William Grieco sold 2,000 shares of the company’s stock in a transaction on Friday, June 16th. The stock was sold at an average price of $45.42, for a total value of $90,840.00. Following the completion of the sale, the director now owns 47,013 shares in the company, valued at $2,135,330.46. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Randall P. Goldberg sold 4,925 shares of the company’s stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $45.18, for a total value of $222,511.50. Following the completion of the sale, the vice president now owns 10,607 shares of the company’s stock, valued at approximately $479,224.26. The disclosure for this sale can be found here. In the last 90 days, insiders sold 881,619 shares of company stock valued at $40,440,669. Insiders own 11.10% of the company’s stock.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
